GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries

INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a relatively new class of injectable drugs used in the treatment of type 2 diabetes (T2D). This retrospective database study evaluated real-world treatment patterns of T2D patients initiating GLP-1 RAs in Belgium (BE), France (F...

Descripción completa

Detalles Bibliográficos
Autores principales: Divino, Victoria, DeKoven, Mitch, Khan, Farhad Ali, Boye, Kristina S., Sapin, Hélène, Norrbacka, Kirsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306123/
https://www.ncbi.nlm.nih.gov/pubmed/28070733
http://dx.doi.org/10.1007/s13300-016-0224-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306123/
https://www.ncbi.nlm.nih.gov/pubmed/28070733
http://dx.doi.org/10.1007/s13300-016-0224-5

Ejemplares similares